These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 2613281)
1. Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice. Andrew ME Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():339-41. PubMed ID: 2613281 [TBL] [Abstract][Full Text] [Related]
2. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Coupar BE; Andrew ME; Both GW; Boyle DB Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144 [TBL] [Abstract][Full Text] [Related]
3. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707 [TBL] [Abstract][Full Text] [Related]
4. Recombinant vaccinia immunization in the presence of passively administered antibody. Johnson MP; Meitin CA; Bender BS; Small PA Vaccine; 1993; 11(6):665-9. PubMed ID: 8322491 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Grandpre LE; Duke-Cohan JS; Ewald BA; Devoy C; Barouch DH; Letvin NL; Reinherz EL; Baden LR; Dolin R; Seaman MS Vaccine; 2009 Mar; 27(10):1549-56. PubMed ID: 19168105 [TBL] [Abstract][Full Text] [Related]
6. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Andrew ME; Coupar BE; Boyle DB; Ada GL Scand J Immunol; 1987 Jan; 25(1):21-8. PubMed ID: 3492756 [TBL] [Abstract][Full Text] [Related]
7. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Flexner C; Hügin A; Moss B Nature; 1987 Nov 19-25; 330(6145):259-62. PubMed ID: 3118219 [TBL] [Abstract][Full Text] [Related]
8. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins. Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473 [TBL] [Abstract][Full Text] [Related]
9. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Berinstein A; Tami C; Taboga O; Smitsaart E; Carrillo E Vaccine; 2000 Apr; 18(21):2231-8. PubMed ID: 10717342 [TBL] [Abstract][Full Text] [Related]
10. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals. Viner KM; Girgis N; Kwak H; Isaacs SN Virology; 2007 May; 361(2):356-63. PubMed ID: 17188733 [TBL] [Abstract][Full Text] [Related]
11. [Peroral immunization--a method for enhancing the safety of the recombinant vector (the vaccinia virus)]. Podkuĭko VN; Vorob'ev AA; Krasnianskiĭ VP; Patrikeev GT; Mikhaĭlov VV; Dorokhina TV; Makhlaĭ AA; Dykanov GA Vestn Ross Akad Med Nauk; 1993; (2):39-44. PubMed ID: 7688619 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara. Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585 [TBL] [Abstract][Full Text] [Related]
13. Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus. Kerr PJ; Jackson RJ Vaccine; 1995 Dec; 13(17):1722-6. PubMed ID: 8719525 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins. Jakeman KJ; Smith H; Sweet C J Gen Virol; 1989 Jun; 70 ( Pt 6)():1523-31. PubMed ID: 2732721 [TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccinia virus with influenza hemagglutinin protects old mice from influenza infection. Ben-Yehuda A; Ehleiter D; Hu AR; Weksler ME Trans Assoc Am Physicians; 1992; 105():177-81. PubMed ID: 1308994 [No Abstract] [Full Text] [Related]
16. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection. Ben-Yehuda A; Ehleiter D; Hu AR; Weksler ME J Infect Dis; 1993 Aug; 168(2):352-7. PubMed ID: 8335970 [TBL] [Abstract][Full Text] [Related]
17. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536 [TBL] [Abstract][Full Text] [Related]
18. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. Bender BS; Rowe CA; Taylor SF; Wyatt LS; Moss B; Small PA J Virol; 1996 Sep; 70(9):6418-24. PubMed ID: 8709274 [TBL] [Abstract][Full Text] [Related]
19. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus. Doherty PC; Allan W; Boyle DB; Coupar BE; Andrew ME J Infect Dis; 1989 Jun; 159(6):1119-22. PubMed ID: 2786041 [No Abstract] [Full Text] [Related]
20. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice. Andrew ME; Coupar BE Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]